- Home
- TREE vs ABEO Comparison
TREE vs ABEO Comparison
Compare TREE & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TREE | ABEO |
|---|---|---|
| Founded | 1996 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 399.5M |
| IPO Year | 2008 | 2005 |
Fundamental Metrics
Financial Performance| Metric | TREE | ABEO |
|---|---|---|
| Price | $24.21 | $5.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $71.25 | $20.00 |
| AVG Volume (30 Days) | 369.9K | ★ 1.3M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 443.31 | 165.16 |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $1,117,324,000.00 | $2,998,000.00 |
| Revenue This Year | $19.03 | $1,024.31 |
| Revenue Next Year | $7.07 | $145.42 |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | 24.12 | ★ 258.18 |
| 52 Week Low | $23.82 | $4.00 |
| 52 Week High | $68.93 | $7.65 |
Technical Indicators
Market Signals| Indicator | TREE | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 30.69 | 34.54 |
| Support Level | N/A | $4.91 |
| Resistance Level | $39.74 | $5.55 |
| Average True Range (ATR) | 1.20 | 0.25 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 9.06 | 3.49 |
Price Performance
Historical ComparisonAbout TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.